Cubist Systematic Strategies’s Lyell Immunopharma LYEL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,438
| Closed | -$64.1K | – | 2127 |
|
|
2024
Q1 | $64.1K | Sell |
1,438
-1,645
| -53% | -$73.4K | ﹤0.01% | 1879 |
|
|
2023
Q4 | $120K | Buy |
+3,083
| New | +$120K | ﹤0.01% | 1756 |
|
|
2023
Q2 | – | Sell |
-2,473
| Closed | -$117K | – | 2698 |
|
|
2023
Q1 | $117K | Buy |
+2,473
| New | +$117K | ﹤0.01% | 2381 |
|
|
2022
Q4 | – | Sell |
-1,506
| Closed | -$221K | – | 3444 |
|
|
2022
Q3 | $221K | Buy |
+1,506
| New | +$221K | ﹤0.01% | 2933 |
|
|
2022
Q2 | – | Sell |
-2,440
| Closed | -$246K | – | 3921 |
|
|
2022
Q1 | $246K | Sell |
2,440
-5,854
| -71% | -$590K | ﹤0.01% | 2926 |
|
|
2021
Q4 | $1.28M | Buy |
8,294
+6,261
| +308% | +$969K | 0.01% | 1727 |
|
|
2021
Q3 | $602K | Buy |
2,033
+1,743
| +601% | +$516K | 0.01% | 1901 |
|
|
2021
Q2 | $94K | Buy |
+290
| New | +$94K | ﹤0.01% | 2718 |
|